Herpetic Eye Disease Is Not a Single Event - Report - MDSpire
Advertisement
Herpetic Eye Disease Is Not a Single Event
Joseph P. Shovlin, OD, FAAO, reviewed diagnosis, management, and emerging evidence related to chronic herpetic eye disease prevention at Optometry's Meeting 2026.
Clinical Report: Herpetic Eye Disease Is Not a Single Event
Overview
Herpetic eye disease, primarily caused by HSV and VZV, presents significant diagnostic and management challenges. Early recognition and differentiation between infectious and inflammatory conditions are crucial for effective treatment and vision preservation.
Background
Herpetic eye disease is a chronic condition that can lead to severe ocular complications if not properly managed. Understanding the clinical patterns of herpetic keratitis is essential for preventing misdiagnosis and reducing the risk of vision loss. With the increasing prevalence of herpes zoster ophthalmicus in an aging population, clinicians must be vigilant in their approach to diagnosis and treatment.
Data Highlights
No numerical data provided in the source material.
Key Findings
HSV-1 is the most common ocular viral pathogen, while HZO prevalence is rising.
Both HSV and VZV establish lifelong latency and can reactivate with declining immunity.
Four major corneal manifestations of HSV include epithelial keratitis, stromal keratitis, endotheliitis, and neurotrophic keratopathy.
Topical and oral antivirals are effective for epithelial disease, while corticosteroids are used for stromal and endothelial inflammation.
Emerging evidence suggests that suppressive valacyclovir therapy can reduce recurrent episodes in selected HZO patients.
Neurotrophic keratopathy presents significant treatment challenges with modern approaches including amniotic membrane therapy and scleral contact lenses.
Clinical Implications
Clinicians should prioritize early recognition of herpetic eye disease and differentiate between infectious and inflammatory conditions to optimize treatment strategies. Long-term monitoring and appropriate antiviral use are essential to prevent complications and preserve vision in affected patients.
Conclusion
Herpetic eye disease requires a comprehensive understanding of its clinical manifestations and management strategies. Effective treatment hinges on timely diagnosis and appropriate therapeutic interventions.
Management of endogenous fungal endophthalmitis is complex, with wide variation in treatment strategies. Systemic markers of disease appear to influence the choice of initial therapy more than ocular findings. Although no definitive evidence favors IV over oral systemic therapy, a comprehensive, multidisciplinary approach that considers ocular involvement is essential to optimize patient outcomes in EFE.
